Dermatologic Reactions to Targeted Therapy-Reference-Cited by-同舟云学术

Dermatologic Reactions to Targeted Therapy

Published:2017-03 Issue:1 Volume:52 Page:83-113
ISSN:0029-6465
Container-title:Nursing Clinics of North America
language:en
Short-container-title:Nursing Clinics of North America

Author:

Barton-Burke Margaret,Ciccolini Kathryn,Mekas Maria,Burke Sean

Publisher

Elsevier BV

Subject

General Nursing

Reference32 articles.

1. Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities;Lacouture;Support Care Cancer,2011

2. Epidermal growth factor receptor inhibitor-associated cutaneous toxicities: an evolving paradigm in clinical management;Lynch;Oncologist,2007

3. Oncology nursing drug handbook;Wilkes,2016

4. Dermatologic infections in cancer patients treated with epidermal growth factor receptor inhibitor therapy;Eilers;J Natl Cancer Inst,2009

5. The skin physical examination. Available at: http://www.siumed.edu/medicine/dermatology/student_information/skinphysicalexam.pdf. Accessed August 22, 2016.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Translation, Cross-Cultural Adaptation, Reliability and Construct Validity of the FACT- EGFRI-18 Quality of Life Instrument from English into Portuguese;Revista Brasileira de Cancerologia;2024-07-04

2. Insights from the molecular docking analysis of EGFR antagonists;Bioinformation;2023-03-31

3. Reaffirming Adverse Events Related to Lung Cancer Survivors’ Target Therapies and Their Apparent Effects on Fear of Cancer Progression, Anxiety, and Depression;Cancer Nursing;2022-12-01

4. Home-based multidisciplinary interventions on skin adverse reactions in EGFR-TKI-treated patients with lung cancer: a protocol for a randomised controlled trial;BMJ Open;2022-11

5. The relationship between medication literacy and skin adverse reactions in non-small-cell lung cancer patients undergoing targeted EGFR-TKI therapy;BMC Cancer;2022-05-03